IntraCellular Therapies (ITCI)
(Real Time Quote from BATS)
$77.43 USD
+0.46 (0.60%)
Updated Sep 20, 2024 02:56 PM ET
3-Hold of 5 3
D Value A Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -0.17 |
EPS Last Quarter | -0.16 |
Last EPS Surprise | 11.11% |
ABR | 1.40 |
Earnings ESP
|
8.20% |
---|---|
Current Year | -0.59 |
Next Year | 0.55 |
EPS (TTM) | -0.87 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 171.97M | 187.92M | 666.17M | 884.86M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 178.10M | 190.60M | 672.83M | 963.70M |
Low Estimate | 164.77M | 185.42M | 656.44M | 809.88M |
Year ago Sales | 126.17M | 132.10M | 464.37M | 666.17M |
Year over Year Growth Est. | 36.30% | 42.25% | 43.46% | 32.83% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.17 | -0.07 | -0.59 | 0.55 |
# of Estimates | 7 | 5 | 8 | 7 |
Most Recent Consensus | -0.07 | -0.06 | -0.61 | 0.55 |
High Estimate | -0.07 | 0.01 | -0.45 | 1.35 |
Low Estimate | -0.26 | -0.12 | -0.80 | -0.43 |
Year ago EPS | -0.25 | -0.30 | -1.46 | -0.59 |
Year over Year Growth Est. | 32.00% | 76.67% | 59.59% | 193.43% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 2 | 2 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 2 | 3 | 4 | 6 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.17 | -0.07 | -0.59 | 0.55 |
7 Days Ago | -0.17 | -0.07 | -0.59 | 0.55 |
30 Days Ago | -0.18 | -0.09 | -0.61 | 0.54 |
60 Days Ago | -0.14 | -0.05 | -0.53 | 0.88 |
90 Days Ago | -0.13 | -0.06 | -0.51 | 0.93 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.16 | 0.01 | -0.46 | 0.27 |
Zacks Consensus Estimate | -0.17 | -0.07 | -0.59 | 0.55 |
Earnings ESP | 8.20% | 113.51% | 22.20% | -50.91% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.16 | -0.16 | -0.30 | -0.25 | NA |
Estimate | -0.18 | -0.31 | -0.44 | -0.59 | NA |
Difference | 0.02 | 0.15 | 0.14 | 0.34 | 0.16 |
Surprise | 11.11% | 48.39% | 31.82% | 57.63% | 37.24% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more